|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
COMMENTARY |
CORRESPONDENCE R.M.M.: rick.maizels{at}ed.ac.uk OR A.S.M.: andrew.macdonald{at}ed.ac.uk
ABSTRACT
There is an ever-increasing understanding of the mechanisms by which pathogens such as bacteria, viruses, and protozoa activate dendritic cells (DCs) to drive T helper type 1 (Th1) responses, but we know much less about how these cells elicit Th2 responses. This gap in our knowledge puts us at a distinct disadvantage in designing therapeutics for certain immune-mediated diseases. However, progress is being made with the identification of novel endogenous tissue factors that can enhance Th2 induction by DCs.
Related Article
| TABLE OF CONTENTS |
|